Group One Trading’s Indaptus Therapeutics INDP Stock Holding History

Group One Trading’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2	Closed	-$2K	–	5487
2019 Q4	$2K	Sell	2 -7	-78%	-$9.66K	﹤0.01%	4901
2019 Q3	$14K	Sell	9 -16	-64%	-$47.6K	﹤0.01%	4485
2019 Q2	$248K	Buy	25 +23	+1,150%	+$290K	﹤0.01%	2692
2019 Q1	$40K	Buy	+2	New	+$35K	﹤0.01%	3674

Other funds holding INDP

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's INDP Position: Q2 2025 in Review

Group One Trading held its Indaptus Therapeutics (INDP) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8254.

Group One Trading first reported a position in INDP in Q4 2018 and has held it in 8 quarters since. The position peaked at $120K in Q1 2019. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.

Group One Trading held 0 shares of Indaptus Therapeutics worth $0 as of Q2 2025.
Group One Trading left its Indaptus Therapeutics share count unchanged in Q2 2025.
Indaptus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2025, its #8254 holding.
Group One Trading first reported a position in Indaptus Therapeutics in Q4 2018 and has held it in 8 quarters since.
Group One Trading's Indaptus Therapeutics position peaked at $120K in Q1 2019.
5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.